Daewoong pharmaceutical

069620.KO

91.73 USD

3.24

+3.66%

Overview

Last close

91.73 usd

Market cap

1.06B usd

52 week high

119.37 usd

52 week low

69.54 usd

Target price

140.99 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.0568

Price/Book Value

1.7484

Enterprise Value

1.36B usd

EV/Revenue

1.3492

EV/EBITDA

11.4998

Key financials

Revenue TTM

998.75M usd

Gross Profit TTM

455.52M usd

EBITDA TTM

124.98M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

1,877.36B usd

Net debt

N/A usd

About

Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.